During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing ...
The global bioscience industry, in 2012, reported 450 mergers and acquisitions (M&A) transactions valued at $67 bill...
Sanjiu Medical and Pharmaceutical is a manufacturing and marketing company for medicines, healthcare products, and medic...
Yunnan Baiyao Group is expanding its forte in the domain of traditional Chinese medicines and is concentrating on stre...
Korea, whose pharma market is being fueled by an aging population with a rising demand for drugs, made it to the top thr...
Australia, with its 2011 revenue of $13 billion, occupies the second largest share of the Asia Pacific pharma market fol...
Clocking $1.3 billion revenue in 2012, Guangzhou Pharmaceutical recorded a growth of over 50 percent. A well-recognize...
Most pharmaceutical companies are sitting on the patent cliff and their drug pipelines are facing severe exhaustion. The...
Australia emerged as the third largest country in terms of the total revenue generated by companies during the calendar ...
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing ...
India emerged as the second largest country in terms of the total revenue generated by companies during the calendar yea...
